Authorization first
Search the current NOTTO list by Haryana, district, hospital, branch, and liver; a network name or old certificate is insufficient.
Authorized liver transplant care in Gurugram
Gurgaon has high-complexity private liver programs serving adults, children, living donors, and selected deceased-donor pathways. Planning must begin with medical urgency and the current NOTTO approved-hospital record for the exact Haryana branch, then independently evaluate recipient candidacy, donor voluntariness and safety, legal authorization, graft anatomy, infection risk, ICU rescue, complete cost, and long-term follow-up.
What should a liver transplant in Gurgaon cost and include?
A 2026 private-care planning range is approximately INR 42,00,000 to 85,00,000+ (USD 43,600 to 88,200+) for recipient and donor pathways, depending on donor type, age, blood-group compatibility, graft anatomy, acuity, ICU course, blood products, infection, biliary or vascular complications, reoperation, and medicines. Authorization, donor evaluation, and deceased-donor allocation cannot be bought or guaranteed.
USD illustrations use INR 96.3665 per USD from the RBI reference displayed for 17 July 2026. Obtain separate recipient, living-donor, complication, and post-discharge assumptions from the authorized Gurgaon branch.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-20
Clinical review: Virello Health Medical Review Team · Editorial review: Virello Health Editorial Team
Planning currency: INR and USD
Search the current NOTTO list by Haryana, district, hospital, branch, and liver; a network name or old certificate is insufficient.
Living-related or otherwise lawful living donation and deceased donation follow different medical, legal, allocation, timing, and cost pathways.
An uncomplicated recipient may remain roughly two to three weeks; the donor usually has a shorter separate admission and recovery plan.
International recipients commonly need six to ten weeks near the program for frequent laboratories, medicine adjustment, imaging, and urgent access.
Transplant hepatology and surgery, donor team, transplant anesthesia and ICU, imaging and intervention, infection, blood bank, pathology, pharmacy, and coordination.
Why this city
Gurgaon can fit patients seeking a high-volume private program, airport-oriented logistics, and integrated hepatology, surgery, radiology, critical care, and liver oncology. Medanta publicly documents these services, while NOTTO is the correct authority check. Program volume or promotional success claims should never replace current authorization, case-matched outcome definitions, donor protection, rescue capability, and transparent written scope.
Large private campuses may coordinate liver physicians, surgeons, anesthetists, intensive care, intervention, pathology, infection, blood bank, dialysis, and rehabilitation in one system.
Gurgaon programs publicly describe substantial living-donor work; patients must still ask for donor-specific morbidity, readmission, reoperation, and independent follow-up data.
NOTTO allocation documents identify Gurgaon hospitals in the broader NCR network context, but listing eligibility, allocation, state coordination, and timing remain governed processes.
Advanced imaging, incompatible transplantation, pediatric care, imported medicines, ICU, and nearby accommodation can create a higher total than the headline operation estimate.
Candidate context
Potential recipients include selected patients with decompensated cirrhosis, acute liver failure, unresectable liver cancer within accepted criteria, metabolic or cholestatic disease, and other irreversible liver conditions. Candidacy depends on severity, reversibility, cancer status, infection, heart and lung health, kidneys, nutrition, frailty, adherence, psychosocial support, and whether transplantation offers meaningful benefit.
Serial liver tests, INR, sodium, complications, imaging, endoscopy, treatment response, and transplant scoring establish severity and whether further medical care can stabilize the liver.
Tumor number, size, vessel involvement, spread, biology, response to bridging treatment, and accepted program criteria determine transplant eligibility.
Heart, lungs, kidneys, infection, nutrition, muscle loss, frailty, substance use, cognition, support, and ability to take medicines affect risk and benefit.
A living donor needs independent medical and psychosocial clearance and applicable authorization; deceased-donor access requires listing and allocation, not a reserved date.
Urgency and travel safety
Confusion, vomiting blood, black stool, severe breathlessness, shock, low urine, fever, or rapidly deepening jaundice needs immediate emergency care.
Do not board a commercial flight.
New jaundice with coagulopathy, altered behavior, drowsiness, or severe illness can worsen quickly and needs specialist ICU assessment.
Transfer must be medically coordinated.
Repeated fluid buildup, infection, bleeding, kidney dysfunction, or encephalopathy warrants prompt transplant-center review while local stabilization continues.
Send recent admission details.
Remote records can establish missing recipient tests, likely donor questions, authorization steps, city duration, and a conditional estimate.
No donor should travel before preliminary screening.
Treatment options
Technique, disease extent, devices, medicines, prior treatment, and patient health can change the team, hospital support, stay, recovery, and estimate.
A medically and legally accepted donor gives a liver segment selected through volumetry and detailed vascular and biliary mapping.
Donor welfare is independent of recipient urgency.
A listed patient may receive a compatible deceased-donor organ under applicable allocation rules when an offer becomes available.
Timing and organ offer cannot be guaranteed.
Selected programs may use additional immune treatment or complex reconstruction when standard compatibility or anatomy is unavailable.
Risk, medicine, tests, and cost differ.
Endoscopy, drainage, infection treatment, cancer-directed therapy, nutrition, dialysis, interventional procedures, or supportive care may stabilize or replace transplant.
Reassess benefit and candidacy over time.
City treatment pathway
Share diagnosis, recent admissions, serial liver and kidney tests, INR, sodium, blood group, imaging, endoscopy, infections, tumors, medicines, and current stability.
Confirm the exact Gurgaon hospital address and liver authorization on NOTTO, then verify adult or pediatric scope, donor route, ICU, intervention, and current team.
Recipient benefit and risk are assessed separately from donor medical, anatomic, psychosocial, voluntariness, financial, and legal review.
Applicable authorization, graft size and anatomy, blood plan, infection strategy, anesthesia, ICU, surgical teams, and contingency costs are documented.
The recipient and living donor receive separate surgery and monitoring; graft blood flow, bile ducts, kidney function, infection, bleeding, and rejection are watched closely.
Frequent laboratories, drug-level adjustment, imaging, wound review, nutrition, rehabilitation, and urgent access continue before home-country transfer.
City cost scenarios
These dated scenarios help compare scope; they are not guaranteed packages. A hospital estimate should replace them after the reports, procedure variant, likely stay, and special requirements are reviewed.
| Scenario | INR | USD | Patient context | Planning scope |
|---|---|---|---|---|
| Expected living-donor pathway | INR 42,00,000 - 52,00,000 | USD 43,600 - 54,000 | Accepted recipient and donor, compatible pathway, standard anatomy, planned operation, expected ICU and ward course, and no major complication. | Written recipient and donor work-up, both operations, routine consumables, defined ICU and ward days, blood allowance, pathology, medicines, and scheduled early follow-up. |
| Complex recipient or donor pathway | INR 52,00,000 - 68,00,000 | USD 54,000 - 70,600 | Pediatric size, incompatible blood group, difficult anatomy, significant portal clot, renal support, higher infection risk, or prolonged ICU monitoring. | Expanded pre-transplant testing, immune treatment or technical work, additional blood and critical-care allowance, and closer follow-up; every non-routine item needs confirmation. |
| High-acuity or complicated course | INR 68,00,000 - 85,00,000+ | USD 70,600 - 88,200+ | Acute liver failure, multi-organ dysfunction, major bleeding, vascular or biliary complication, severe infection, graft dysfunction, reoperation, or prolonged ventilation. | Risk reserve rather than a ceiling. Re-transplant, extended dialysis, high-cost anti-infectives, long ICU, rehabilitation, travel, and accommodation may exceed the range. |
Usually included
Named transplant consultations and listed liver, cancer, heart, lung, kidney, infection, nutrition, and anesthesia investigations.
Outside tests may need repeat validation.
Separate medical, imaging, surgical, psychosocial, and anesthesia work-up when the donor route proceeds.
Authorization costs and exclusions must be clear.
Donor operation and recipient transplant, operating rooms, clinicians, routine graft preservation, standard consumables, and pathology.
Ask about special devices and reconstruction.
Defined transplant ICU and ward days, nursing, standard medicines, room class, routine imaging, and blood-product allowance.
Obtain daily overstay rates.
Scheduled laboratory and clinic reviews, medicine adjustment, wound care, diet and activity teaching, and discharge records.
Confirm duration and drug inclusions.
Confirm separately
Repeat CT or MRI, angiography, biopsy, cardiac procedure, infection treatment, tumor therapy, dental work, or donor reassessment may be extra.
Ask which result changes eligibility.
Apheresis, immune medicines, special reconstruction, additional intervention, paired exchange logistics, or unusual blood preparation changes price.
Use a named revised pathway.
Reoperation, dialysis, prolonged ventilation, embolization, drainage, severe infection, rejection therapy, or extended ICU commonly exceeds a routine package.
Request unit and daily rates.
Immunosuppressants, antivirals, antifungals, monitoring tests, diabetes or blood-pressure medicines, and supplements continue after discharge.
Build a monthly budget.
Visa, donor and recipient flights, attendants, hotel, meals, transport, longer stay, and home follow-up are separate.
Use flexible travel arrangements.
Estimate variables
Compare the assumptions behind each number, not only the top and bottom of the range.
Acute failure, encephalopathy, bleeding, kidney dysfunction, ventilation, infection, and multi-organ support increase urgency and critical-care use.
Current condition can change daily.
Graft size, steatosis, vascular and bile-duct variants, age, health, and recipient size affect feasibility and surgical complexity.
A willing donor may be declined.
ABO-incompatible or sensitized pathways may require additional testing, immune therapy, apheresis, and infection surveillance.
Ask for the complete protocol.
Tumor assessment, bridging treatment, portal-vessel reconstruction, and pathology can alter candidacy, operation, and recurrence monitoring.
Send original imaging.
Bleeding, graft dysfunction, rejection, infection, renal failure, neurologic problems, or respiratory support can dominate final cost.
Packages have limits.
Drug levels, frequent labs, imaging, procedures, medicines, donor follow-up, lodging, and home specialist access extend beyond the operation.
Model at least the first year.
Hospital capability
Verify liver transplant permission for the precise Gurgaon address using NOTTO; registration for another organ or branch does not establish liver authorization.
The program should separate donor advocacy, medical and psychosocial review, consent, authorization, surgery, records, and long-term follow-up from recipient pressure.
Adult or pediatric hepatology, transplant surgery, anesthesia, ICU, diagnostic and interventional radiology, endoscopy, pathology, infection, blood bank, and pharmacy should be available.
Round-the-clock Doppler or imaging, angiography and intervention, endoscopy, blood products, dialysis, ventilation, drainage, and reoperation should be accessible on campus.
The center must supply separate recipient and donor summaries, graft anatomy, operation and pathology records, medicines, drug targets, warning signs, and emergency contacts.
Shortlist questions
Is this exact Haryana branch currently approved for liver transplantation, and what is the registration detail?
Recheck near admission.
Request adult or pediatric, living or deceased, compatible or incompatible outcomes with definitions, time period, exclusions, donor events, and follow-up completeness.
Do not rely on one promotional percentage.
Who can stop donation, protect confidentiality, assess coercion, explain personal risk, and provide care if the recipient worsens?
Withdrawal must remain possible.
Who leads hepatology, recipient and donor surgery, anesthesia, ICU, intervention, infection, blood bank, nephrology, and pharmacy?
Confirm current availability.
Separate recipient and donor tests, operations, ICU days, blood, devices, complications, medicines, follow-up, overstay, and refund terms.
Use dated assumptions.
Who will monitor graft and kidney tests, drug levels, infection, diabetes, blood pressure, cancer surveillance, vaccination, and urgent deterioration?
Establish the receiving team first.
Treating team
Confirms irreversible disease, optimizes complications, reviews cancer and infection, manages listing, and directs lifelong graft and medicine monitoring.
Independently assess feasibility and donor safety, plan graft and reconstruction, perform two operations, and manage surgical complications.
Manage bleeding, circulation, ventilation, kidneys, coagulation, glucose, infection, pain, and early graft function for donor and recipient.
Radiology and intervention, endoscopy, pathology, microbiology, infectious disease, nephrology, blood bank, pharmacy, nutrition, rehabilitation, psychosocial, and coordination complete the program.
City care ecosystem
NOTTO documents Gurgaon hospitals within the NCR transplant context, but patients must verify current organ and branch authorization rather than infer it from reputation.
Major private systems provide liver imaging, intervention, endoscopy, pathology, oncology, and critical care; confirm that emergency services are on the operating campus.
The city can simplify international arrival, yet recipients should remain close to the program and avoid flying until clinically cleared.
Delhi services may support selected pathology, organ-sharing, or specialty referrals, but responsibility, ambulance transfer, authorization, and records must be explicit.
Alternative cities
No city is the universal choice. Compare referral depth, timing, travel burden, continuity, and complete cost around the individual case.
Compare authorized institutional and private liver programs when a specific team, public pathway, donor process, or complexity profile fits better.
Authorization and allocation rules still apply.
Another metro may suit pediatric, incompatible, retransplant, vascular, metabolic, or family-support needs.
Compare case-matched pathways and total stay.
Local hepatology, infection control, nutrition, endoscopy, fluid management, and cancer bridging may improve safety before transplantation.
Do not delay an emergency transfer.
Local logistics
Frequent labs, fever, jaundice, vomiting, low urine, wound change, or abnormal liver tests may require same-day review; minimize Gurgaon traffic exposure.
The donor needs an advocate, caregiver, lodging, food, transport, follow-up, and a return-to-work plan independent of recipient recovery.
Choose reliable water and food, private hygiene, ventilation, lift access, clean medication storage, caregiver space, and rapid hospital transport.
Authorization, donor findings, recipient instability, ICU recovery, complications, and laboratory trends can alter operation and departure dates.
Maintain prescriptions, temperature and storage guidance, hand-luggage supply, dosing times, interaction list, and backup availability.
Recipient and living donor have different wound, mobility, clot, organ-function, medicine, and follow-up criteria and should each be assessed.
Treatment timeline
The program assesses urgency, likely indication, missing investigations, travel safety, and whether potential donor information should be requested.
Liver severity, cancer, infection, heart, lungs, kidneys, nutrition, frailty, anesthesia, and psychosocial readiness are reviewed.
A separate team assesses medical fitness, anatomy, graft size, voluntariness, relationship evidence, consent, and required committee approval.
Donor hepatectomy and recipient transplant proceed with blood, ICU, intervention, and reoperation contingencies prepared.
Graft flow and function, bile ducts, infection, rejection, kidneys, wounds, nutrition, mobility, and medicines are monitored closely.
Stable trends, drug supply, recipient and donor records, emergency contacts, receiving clinicians, and travel clearance support return.
Recovery and continuity
Fever, jaundice, pale stool, dark urine, severe pain, vomiting, confusion, low urine, breathlessness, bleeding, or wound discharge requires urgent contact.
Take immunosuppression at agreed times, complete monitoring, and check all antibiotics, herbal products, grapefruit-like foods, and new prescriptions for interactions.
Liver and kidney tests, blood counts, glucose, electrolytes, and drug levels are interpreted together; one abnormal value may trigger repeat testing, imaging, or biopsy.
Food and water safety, hand hygiene, dental care, vaccinations, exposure advice, and rapid fever assessment are tailored to immune suppression.
The donor needs independent wound, liver, pain, emotional, activity, and work review even when the recipient is unwell or has returned home.
Blood pressure, diabetes, kidneys, bone health, skin and other cancer screening, cardiovascular risk, adherence, and liver-disease recurrence remain relevant.
Risks and edge cases
Health, anatomy, graft size, steatosis, psychosocial findings, legal evidence, or personal withdrawal may end the planned living-donor route.
Do not pressure or conceal information.
Major bleeding, hepatic artery or portal vein thrombosis, or outflow obstruction can require transfusion, intervention, or urgent reoperation.
Rescue availability matters.
Leak, narrowing, collection, or infection may require imaging, drainage, endoscopy, repeated procedures, or surgery.
These can occur after discharge.
Abnormal function may reflect rejection, preservation injury, vessel or bile-duct problem, infection, medicine toxicity, or recurrent disease.
Never self-change immunosuppression.
Immune suppression, prior infections, long surgery, and critical illness can lead to bacterial, viral, fungal, kidney, lung, or neurologic complications.
Treatment may be prolonged.
Listing does not promise an organ or date; health may improve, worsen, become unsuitable, or require repeated readiness while waiting.
Maintain local care and contact.
Reports for review
A transplant opinion requires serial data and original imaging, not only a diagnosis. Provide the recipient’s recent trajectory, complications, infection and cancer evidence, cardiopulmonary and renal status, medicines, and blood group. Potential-donor information should be shared privately and only through the authorized program’s process.
Upload medical reportsThese records define indication, urgency, and technical feasibility.
Bilirubin, INR, albumin, creatinine, sodium, blood counts, blood group, transplant-score history, and dates.
Recent CT or MRI DICOM, Doppler, reports, portal thrombosis, prior interventions, tumor dimensions, and comparison studies.
Fluid buildup, encephalopathy, bleeding, infections and cultures, kidney injury, ventilation, endoscopy, drainage, admissions, and procedures.
Viral, alcohol-related, metabolic, autoimmune, cholestatic, genetic, cancer, and other diagnoses with medicines and response.
These details support safety, authorization, and continuity.
Heart, lung, kidney, infection, nutrition, frailty, dental, cancer-screening, surgery, transfusion, allergy, and anesthesia records.
Age, blood group, relationship, country, health and surgery history, medicines, pregnancy history when relevant, and voluntary contact route.
Passports, relationship evidence, domicile or authorization documents requested by the hospital, photographs, and certified translations where required.
Visa, attendants, accommodation, finances, home hepatologist, laboratory, drug-level capability, emergency hospital, and medicine availability.
International patient notes
Use NOTTO’s current approved-hospital list and the program’s authorized coordinator; no intermediary can guarantee donor or committee approval.
Apply through Indian Visa Online with accurate recipient and donor or attendant documentation from the exact Gurugram branch.
Payment for an organ, fabricated relationship evidence, coercion, or promised authorization is unsafe and unlawful; donor voluntariness is fundamental.
Verify immunosuppressant supply, drug-level testing, infection support, interventional access, emergency contact, and record transfer before leaving India.
Procedure-specific planning
A credible Gurgaon liver pathway separates three decisions: whether the recipient benefits, whether the donor can proceed without unacceptable risk or pressure, and whether the exact hospital is legally and operationally ready. It also prices rescue care rather than assuming an uncomplicated course.
Confirm current NOTTO evidence for liver transplantation at the precise Haryana address and clarify adult, pediatric, living, and deceased routes.
Recheck before admission.
The donor should receive private counseling, personal risk information, a withdrawal route, and care not conditional on recipient outcome.
Recipient urgency cannot override donor safety.
CT volumetry, liver quality, vascular and bile-duct variants, recipient size, portal flow, and reconstruction options shape feasibility.
Ask what could cancel surgery.
Listing, allocation, organ quality, matching, travel readiness, and acceptance remain governed and unpredictable.
No one can sell a waiting time.
Identify 24-hour Doppler, intervention, endoscopy, blood, dialysis, ventilation, anti-infectives, biopsy, and reoperation capability.
Confirm they are on the same campus.
Add immunosuppression, prophylaxis, drug levels, labs, imaging, procedures, donor reviews, lodging, flights, and home care to hospital cost.
The operation is one part of the total.
Consultation checklist
Ask for the current organ-specific registration evidence and the applicable Haryana authorization pathway.
Discuss diagnosis, severity, reversibility, cancer criteria, competing risks, timing, and non-transplant alternatives.
Identify the independent advocate, confidentiality, medical thresholds, psychosocial review, withdrawal process, and long-term follow-up.
Review compatibility, graft size, liver quality, vascular and biliary anatomy, portal flow, and backup strategy.
Clarify repeat testing, incompatible work, blood, ICU, dialysis, infection, intervention, reoperation, medicines, and extended stay.
Name the clinician and laboratory responsible for liver and kidney tests, drug levels, infection, metabolic health, surveillance, and emergencies.
Common questions
An expected living-donor pathway may be around INR 42,00,000 to 52,00,000. Complex care may reach INR 52,00,000 to 68,00,000, while high-acuity or complicated treatment can exceed INR 85,00,000, about USD 88,200+. Ask for separate donor, recipient, ICU, medicine, and follow-up assumptions.
Search the current NOTTO approved-hospital list for Haryana and liver, then verify the precise Gurgaon or Gurugram address. Authorization is organ and branch specific. Confirm the current team, ICU, intervention, blood bank, infection, donor, and follow-up capability separately.
Only when the donation is lawful, voluntary, medically acceptable, and receives required scrutiny and authorization. Relationship and identity records, independent interviews, psychosocial assessment, and safeguards against commercial influence may apply. No facilitator can promise approval.
No. Blood group, liver health, graft size, anatomy, overall health, psychosocial findings, pregnancy considerations, legal evidence, and personal choice can prevent donation. The donor may withdraw and should have confidential support.
Eligibility, registration, state and national rules, allocation priority, organ availability, matching, and program acceptance must be checked directly with an authorized center. Listing does not guarantee an organ, date, or outcome.
An uncomplicated recipient may need six to ten weeks near the transplant team, while the donor follows a separate recovery and travel plan. Infection, rejection, abnormal tests, wound issues, intervention, or weak home support can extend either stay.
Repeat evaluation, incompatible protocols, special devices, excess blood, prolonged ICU, dialysis, severe infection, intervention, reoperation, post-discharge medicines, long follow-up, travel, lodging, and home care may be excluded or capped.
Fever, jaundice, pale stool, dark urine, vomiting, severe abdominal pain, confusion, low urine, breathlessness, bleeding, wound discharge, or inability to take immunosuppression requires immediate contact with the transplant team or emergency care.
Possibly, but each needs independent clearance based on wound, liver function, mobility, clot risk, medicines, hydration, pain, and follow-up. The recipient also needs stable graft tests and immunosuppressant supply. Flexible tickets and capable assistance are prudent.
Send serial liver, kidney, INR and sodium results, blood group, admission summaries, CT or MRI DICOM, Doppler, endoscopy, infections and cultures, tumor work-up, medicines, heart and lung records, and brief potential-donor relationship and health information through the program’s secure route.
Review and sources
This guide combines NOTTO authorization, law, forms, allocation material, current Gurgaon campus service evidence, and Virello Health private-care benchmarks. Scenarios separate expected living-donor, complex, and high-acuity courses and include donor and recipient planning. They are not tariffs, legal approvals, organ offers, or outcome claims. The authorized program must review current recipient records, independently evaluate any donor, complete applicable approvals, and issue a dated written estimate.
This page does not diagnose liver disease, establish transplant candidacy, approve a donor, allocate an organ, select a hospital, or guarantee cost, timing, graft function, or survival. Unstable patients need immediate local care. Recipient, donor, legal, allocation, anesthesia, and treatment decisions belong to authorized professionals and applicable authorities after complete assessment.
National Organ and Tissue Transplant Organisation · Accessed 2026-07-20
Supports: Current hospital-, branch-, state-, and organ-specific authorization verification.
National Organ and Tissue Transplant Organisation · Accessed 2026-07-20
Supports: Living donation, authorization, hospital registration, and legal-governance context.
National Organ and Tissue Transplant Organisation · Accessed 2026-07-20
Supports: Official donor, recipient, hospital, identity, and authorization documentation framework.
Medanta · Accessed 2026-07-20
Supports: Campus-specific hepatology, surgery, anesthesia, critical care, radiology, pediatric, and liver-oncology service evidence.
National Organ and Tissue Transplant Organisation · Accessed 2026-07-20
Supports: Official NCR network context listing Gurgaon transplant hospitals; liver authorization still requires the live approved list.
National Organ and Tissue Transplant Organisation · Accessed 2026-07-20
Supports: Deceased-donor listing and allocation context.
Government of India · Accessed 2026-07-20
Supports: Official visa application route for patients, donors, and attendants.
Reserve Bank of India · Accessed 2026-07-20
Supports: INR 96.3665 per USD conversion dated 17 July 2026.
Related planning
Compare the Hyderabad pathway, provider depth, travel burden, and follow-up model for liver transplant.
Compare the Kochi pathway, provider depth, travel burden, and follow-up model for liver transplant.
Review a separate spine surgery pathway in Gurgaon with its own team, timing, and recovery needs.
Questions about city or hospital options? Email support@virellohealth.com.